Dexmedetomidine and arousal affect subthalamic neurons

Movement Disorders

Volumn 23, Issue 9, 2008, Pages 1317-1320

  Elias, William Jeffrey ^a   Durieux, Marcel E ^a   Huss, Diane ^b   Frysinger, Robert C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Deep brain stimulation; Dexmedetomidine; Microelectrode recording; Subthalamic nucleus

Indexed keywords

DEXMEDETOMIDINE;

ADULT; ANESTHESIA; AROUSAL; ARTICLE; BISPECTRAL INDEX; BRAIN DEPTH RECORDING; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONSCIOUSNESS LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MALE; MICROELECTRODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; SEDATION; SUBTHALAMIC NUCLEUS; TRANQUILIZING ACTIVITY; WAKEFULNESS;

ACTION POTENTIALS; ANALGESICS, NON-NARCOTIC; AROUSAL; DEEP BRAIN STIMULATION; DEXMEDETOMIDINE; HUMANS; MICROELECTRODES; NEURONS; PARKINSONIAN DISORDERS; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS;

EID: 52649100591     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22080     Document Type: Article

References (13)

1. Hardman CD, Henderson JM, Finkelstein DI, Horne MK, Paxinos G, Halliday GM. Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J Comp Neurol 2002;445:238-255.
2. Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of etectrophysiological guidance. [see comment]. J Neurosurg 2002: 97:591-597.
3. Kirschman DL, Milligan B, Wilkinson S, et al. Pallidotomy microelectrode targeting: neurophysiology-based target refinement. [see comment], Neurosurgery 2000;46:613-622.
4. Hutchison WD, Lang AE, Dostrovsky JO, Lozano AM. Pallidal neuronal activity: implications for models of dystonia. Ann Neutor 2003;53:480-488.
5. Bohmdorfer W, Schwarzinger P, Binder S, Sporn P. Temporary suppression of tremor by remifentanil in a patient with Parkinson's disease during cataract extraction under local anesthesia. Anaesthesist 2003;52:795-797.
6. Maltete D, Navarro S, Welter ML, et al. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol 2004;61:390-392.
7. Hertel F, Zuchner M, Weimar I, et al. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia. Neurosurgery 2006;59:E1138.
8. Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care 2001;7:221-226.
9. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery 2005;57(1 Suppl):1-10.
10. Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006;103:1224-1228.
11. Stefani A, Galati S, Peppe A, et al. Spontaneous sleep modulates the firing pattern of parkinsonian subthalamic nucleus. Exp Brain Res 2006; 168:277-280.
12. Hariz MI, Krack P, Melvill R, et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2003;80:96-101.
13. Singh H. Bispectral index (BIS) monitoring during propofol-induced sedation and anaegthesia. Eur J Anaesthesiol 1999; 16:31-36.